Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Grass pollen-specific CD4+ T-cell receptors (TCRs) are specialized protein complexes on the surface of helper T lymphocytes that mediate the immune system's response to environmental allergens. These receptors specifically recognize peptide fragments from grass pollen proteins, such as Phl p 1 and Phl p 5, when they are presented by Major Histocompatibility Complex (MHC) class II molecules (Wambre et al., 2012, Science Translational Medicine). In sensitized individuals, the interaction between the TCR and the MHC-peptide complex triggers the activation of Th2 cells, leading to the release of cytokines like IL-4 and IL-13 (Archila et al., 2014, Journal of Immunology). This process is fundamental to the development of Type I hypersensitivity, driving IgE production and subsequent mast cell degranulation. These TCRs are the primary targets for allergen-specific immunotherapy (AIT), which seeks to modify the immune response through gradual desensitization (Durham & Shamji, 2023, Nature Reviews Immunology). By modulating TCR signaling through chronic exposure, AIT can induce T-cell anergy or promote the differentiation of IL-10-secreting regulatory T cells. Consequently, these receptors are critical for both the manifestation of allergic disease and the success of disease-modifying treatments.
Induction of immune tolerance through T-cell anergy, deletion of allergen-specific Th2 cells, and the promotion of regulatory T-cell (Treg) differentiation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Grass pollen-specific CD4+ T-cell receptor (TCR).